Chinese researchers have unveiled a groundbreaking innovation in medical science—a ‘bone glue’ capable of mending fractures in as little as three minutes. This revolutionary product, named Bone-02, promises to transform the treatment of bone injuries, which affect millions globally each year. According to a Lancet study, approximately 178 million fractures occur annually worldwide, with 18.3 million cases reported in the United States alone. Traditional fracture treatments often involve invasive procedures, such as the use of plates, rods, and screws, which can require additional surgeries for removal, prolonging patient discomfort and recovery time. Bone-02, inspired by the adhesive properties of oysters, offers a non-invasive alternative. It is injected directly into the fracture site, bonding bone fragments swiftly and effectively. The glue is particularly beneficial for treating smaller or awkwardly located fractures, where traditional methods may be unsuitable. Additionally, it minimizes the risk of infection and rejection, addressing significant challenges in fracture management. This innovation marks a significant leap forward in medical technology, potentially rendering complex treatments obsolete and improving patient outcomes globally.